(S (NP (NP (DT The) (NML (NN COVID) (HYPH -) (CD 19)) (NN pandemic)) (VP (VBN caused) (PP (IN by) (NP (DT the) (NML (NNP SARS) (HYPH -) (NNP CoV) (HYPH -) (NNP 2)) (NN virus))))) (VP (VBZ has) (VP (VBN spread) (ADVP (RB rapidly)) (ADVP (RB worldwide)) (, ,) (S (VP (VBG leading) (PP (IN to) (NP (DT a) (JJ global) (NN outbreak))))))) (. .))
(S (NP (JJS Most) (NML (NML (NNS governments)) (, ,) (NML (NNS enterprises)) (, ,) (CC and) (NML (JJ scientific) (NN research))) (NNS institutions)) (VP (VBP are) (VP (VBG participating) (PP (IN in) (NP (DT the) (NML (NN COVID) (HYPH -) (CD 19)) (NN struggle))) (S (VP (TO to) (VP (VB curb) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (DT the) (NN pandemic))))))))) (. .))
(S (PP (IN As) (NP (NP (DT a) (JJ powerful) (NN tool)) (PP (IN against) (NP (NNP COVID) (HYPH -) (NNP 19))))) (, ,) (NP (NML (NML (JJ artificial) (NN intelligence)) (-LRB- -LRB-) (NML (NN AI)) (-RRB- -RRB-)) (NNS technologies)) (VP (VBP are) (ADVP (RB widely)) (VP (VBN used) (PP (IN in) (S (VP (VBG combating) (NP (DT this) (NN pandemic))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN survey))) (, ,) (NP (PRP we)) (VP (VBP investigate) (NP (NP (DT the) (JJ main) (NN scope)) (CC and) (NP (NP (NNS contributions)) (PP (IN of) (NP (NN AI))))) (PP (IN in) (S (VP (VBG combating) (NP (NP (NN COVID) (HYPH -) (CD 19)) (PP (IN from) (NP (NP (NP (DT the) (NNS aspects)) (PP (IN of) (NP (NP (NN disease) (NN detection)) (CC and) (NP (NN diagnosis) (, ,) (NN virology) (CC and) (NN pathogenesis))))) (, ,) (NP (NML (NN drug) (CC and) (NN vaccine)) (NN development)) (, ,) (CC and) (NP (NP (NN epidemic)) (CC and) (NP (NN transmission) (NN prediction)))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP summarize) (NP (NP (DT the) (JJ available) (NNS data) (CC and) (NNS resources)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (ADJP (NP (NN AI)) (HYPH -) (VBN based)) (NML (NNP COVID) (HYPH -) (CD 19)) (NN research)))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (NP (DT the) (JJ main) (NNS challenges)) (CC and) (NP (NP (JJ potential) (NNS directions)) (PP (IN of) (NP (NP (NN AI)) (PP (IN in) (S (VP (VBG fighting) (PP (IN against) (NP (NNP COVID) (HYPH -) (NNP 19)))))))))) (VP (VBP are) (VP (VBN discussed))) (. .))
(S (ADVP (RB Currently)) (, ,) (S (NP (NN AI)) (ADVP (RB mainly)) (VP (VBZ focuses) (PP (IN on) (NP (NP (JJ medical) (NN image) (NN inspection)) (, ,) (NP (NNS genomics)) (, ,) (NP (NN drug) (NN development)) (, ,) (CC and) (NP (NN transmission) (NN prediction)))))) (, ,) (CC and) (S (ADVP (RB thus)) (NP (NN AI)) (ADVP (RB still)) (VP (VBZ has) (NP (NP (JJ great) (NN potential)) (PP (IN in) (NP (DT this) (NN field)))))) (. .))
(S (NP (DT This) (NN survey)) (VP (VBZ presents) (NP (NML (JJ medical) (CC and) (NN AI)) (NNS researchers)) (PP (IN with) (NP (NP (DT a) (JJ comprehensive) (NN view)) (PP (IN of) (NP (NP (DT the) (VBG existing)) (CC and) (NP (NP (JJ potential) (NNS applications)) (PP (IN of) (NP (NN AI) (NN technology)))))))) (PP (IN in) (S (VP (VBG combating) (NP (NN COVID) (HYPH -) (CD 19)) (PP (IN with) (NP (NP (DT the) (NN goal)) (PP (IN of) (NP (VBG inspiring) (NNS researches))))) (S (VP (TO to) (VP (VB continue) (S (VP (TO to) (VP (VB maximize) (NP (NP (DT the) (NNS advantages)) (PP (IN of) (NP (NP (NN AI)) (CC and) (NP (JJ big) (NNS data))))) (S (VP (TO to) (VP (VB fight) (NP (NNP COVID) (HYPH -) (NNP 19))))))))))))))) (. .))
